Trial of Thalidomide, a- Interferon +/- Octreotide in Patients With Unresectable Hepatocellular Carcinoma
Clinical trial NCT00250796 · COMPLETED
Trial details
- NCT number
- NCT00250796
- Sponsor
- University of New Mexico
- Status
- COMPLETED
- Phase
- Phase 2
- Study type
- INTERVENTIONAL
- Start date
- 2000-09-01
- Primary completion
- 2006-01-01
- Enrollment
- 12
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.